News Digest / Income Statements

Income Statements

06:06pm, Tuesday, May 13, 2025
Fifth District Bancorp, Inc. (NASDAQ: FDSB) has released its quarterly results for the period ending March 31, 2025. The report outlines both positive and negative aspects of their income statement, reflecting operational challenges and successes. Key Financial Highlights: Net Income: Increased ...

06:06pm, Tuesday, May 13, 2025
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has released its financial results for the first quarter of 2025, showcasing notable advancements as well as some areas of concern. Positive Aspects: Revenue Growth: Zevra reported revenue of $20.4 million for Q1 2025, significantly up from $3.4 million in...

06:05pm, Tuesday, May 13, 2025
CarParts.com, Inc. (NASDAQ: PRTS) has released its financial results for the first quarter ended March 29, 2025. The company, an online provider of aftermarket auto parts, reported a significant decline in revenue, continuing challenges in the consumer market, and persistent losses. Key Highlight...

06:05pm, Tuesday, May 13, 2025
MDwerks, Inc. (PINK: MDWK) has recently reported its financial results for the first quarter of 2025, highlighting both encouraging developments and significant challenges in its operations. Key Highlights from Q1 2025 Income Statement: Revenue: $513,930, a decline of 25% from $684,660 in Q1 202...

06:04pm, Tuesday, May 13, 2025
Company Overview Premium Resources Ltd. (OTCBB: WSCRF) is primarily engaged in the exploration and evaluation of nickel and copper mining assets in Botswana. Recently, the company underwent a name change from Premium Nickel Resources Ltd. and is focused on advancing the Selebi and Selkirk nickel-...

06:04pm, Tuesday, May 13, 2025
Company Overview: Southland Holdings, Inc. (NYSE: SLND) is a leader in specialty infrastructure construction, engaged in various projects spanning bridges, tunnels, transportation, and facilities across North America. The company has made significant strides in improving operational efficiencies ...

06:03pm, Tuesday, May 13, 2025
Anteris Technologies Global Corp. (NASDAQ: AVR) is currently experiencing significant financial challenges and operational developments as outlined in its recent 10-Q filing for the quarterly period ended March 31, 2025. The company's future relies on ongoing clinical trials and regulatory approv...

06:03pm, Tuesday, May 13, 2025
ClearPoint Neuro, Inc. (NASDAQ: CLPT) has reported its financial performance for the first quarter of 2025, reflecting a mixed bag of results on its income statement. Below are the key highlights of the company's financial position and performance: Total Revenue: Increased by 11% to $8.5 million...

06:03pm, Tuesday, May 13, 2025
Company Overview: Arteris, Inc. (NASDAQ: AIP) is a leading provider of semiconductor system IP technology crucial for managing on-chip communications in System-on-Chip designs. The company has recently reported its financial performance for the first quarter of 2025. Key Financial Highlights: To...

06:02pm, Tuesday, May 13, 2025
Company Overview Dolphin Entertainment, Inc. (NASDAQ: DLPN) is an independent entertainment marketing and production company. The firm provides strategic marketing and publicity services through several subsidiaries, focusing on sectors like film, television, and digital marketing. Q1 2025 Financ...

06:02pm, Tuesday, May 13, 2025
Company Overview: 21Shares Core Ethereum ETF (PINK: CETH) focuses on investing in Ether, aligned with the performance of the CME CF Ether-Dollar Reference Rate. Key Highlights: Assets: As of March 31, 2025, total assets decreased to $8,407,804 from $16,869,879 at year-end 2024. Liabilities: Mini...

06:01pm, Tuesday, May 13, 2025
Brilliant Earth Group, Inc. (NASDAQ: BRLT) continues to navigate a challenging market landscape, as highlighted by its recent income statement for Q1 2025. The company's results indicate both notable strengths and significant challenges. Key Points from Q1 2025 Income Statement: Net Sales: $93.9...

06:01pm, Tuesday, May 13, 2025
Solesence, Inc. (OTCMKTS: NANX) reported its quarterly financial results for the period ending March 31, 2025. Key Financial Highlights: Total Revenue: $14.6 million, up from $9.9 million in Q1 2024, reflecting an increase in consumer product sales. Product Revenue: Increased to $14.6 million co...

06:01pm, Tuesday, May 13, 2025
Kopin Corporation (NASDAQ: KOPN) has released its quarterly report for the period ended March 29, 2025. The following analysis highlights key aspects of their income statement along with various financial metrics. Positive Aspects: Revenue Growth: Total revenues increased to $10.54 million, up f...

06:00pm, Tuesday, May 13, 2025
Tecogen Inc. (NASDAQ: TGEN) has released its quarterly results for the period ending March 31, 2025. The company continues to operate within its sectors of cogeneration systems, maintenance services, and energy production solutions. Positive Aspects: Increased Revenues: Total revenues grew by 17...

05:13pm, Tuesday, May 13, 2025
iCAD, Inc. (NASDAQ: ICAD) has reported its financial results for the quarter ending March 31, 2025, showcasing several noteworthy developments. The company is engaged in AI-powered cancer detection, and aims to create tools that aid in the early detection of breast cancer. Key Takeaways from the ...

05:13pm, Tuesday, May 13, 2025
CyberloQ Technologies, Inc. (OTCMKTS: CLOQ) has released its quarterly results for the period ending March 31, 2025. Below are some key points derived from their latest financial statements. Positive Aspects: CyberloQ has an established platform for fraud prevention technology, successfully inte...

05:12pm, Tuesday, May 13, 2025
Siebert Financial Corp. (NASDAQ: SIEB) has released its quarterly report for the period ending March 31, 2025, detailing both positive gains and some concerns in its income statement. Key Highlights: Net Income: Increased to $8.66 million from $3.69 million in the prior year. Earnings Per Share:...

05:12pm, Tuesday, May 13, 2025
Company Overview: Annovis Bio, Inc. (NYSE: ANVS) is a clinical-stage biopharmaceutical company focused on developing therapeutics for neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson's disease (PD) through its lead product candidate, Buntanetap. Recent Developments: Annovis ...

05:11pm, Tuesday, May 13, 2025
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) has recently released its quarterly report for the period ended March 31, 2025. Here are the key highlights and insights derived from the financial statements and operational updates. Positive Aspects: Clinical Progress: The company has advanced its im...

05:11pm, Tuesday, May 13, 2025
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) presents its latest financial report for the quarter ended March 31, 2025. Financial Overview: Total Revenue: $3.439 million, down from $3.826 million in the same quarter of 2024. Product Revenue, Net: $3.422 million, a slight increase from $3.232 mill...

05:11pm, Tuesday, May 13, 2025
Intuitive Machines, Inc. (NASDAQ: LUNR) Financial Overview As of March 31, 2025, Intuitive Machines reported mixed financial results, with significant fluctuations noted in their income statement compared to the previous year, indicative of their ongoing transitions in operations and strategic po...

05:10pm, Tuesday, May 13, 2025
Company Overview TherapeuticsMD, Inc. (NYSE: TXMD) has made significant changes in its operational focus, pivoting from a women’s healthcare company to a pharmaceutical royalty firm as of December 2022. Operating primarily through licensing agreements, the company generates revenue from royalties...

05:10pm, Tuesday, May 13, 2025
Scientific Industries, Inc. (OTCBB: SCND) recently released its quarterly report for the period ending March 31, 2025, reflecting ongoing challenges and potential for strategic recovery. Positive Aspects: Reduced Losses: The company's net loss decreased to $1,778,500 from $2,051,600 year-on-year...

05:09pm, Tuesday, May 13, 2025
Company OverviewPatriot Gold Corp. (OTCMKTS: PGOL) is a natural resource exploration company focused on acquiring and developing mineral properties, particularly in Nevada. The company's operations recently faced challenges, notably a temporary cessation in revenue from the Moss royalty, amidst o...

05:09pm, Tuesday, May 13, 2025
MediciNova, Inc. (NASDAQ: MNOV) - Q1 2025 Financial Overview MediciNova, Inc., a biopharmaceutical firm based in La Jolla, California, has reported its financial results for the quarter ending March 31, 2025. The company focuses on developing therapeutics targeting serious diseases with unmet med...

05:09pm, Tuesday, May 13, 2025
Company Profile: Metagenomi, Inc. (NASDAQ: MGX) is a precision genetic medicines company focused on curative therapeutics using proprietary genome editing technology. The company has faced significant losses since inception, with a commitment to developing advanced gene editing therapies. Recent ...

05:08pm, Tuesday, May 13, 2025
Company Overview: Lyell Immunopharma, Inc. (NASDAQ: LYEL) specializes in developing CAR T-cell therapies for hematologic malignancies and solid tumors. Their lead product, LYL314, aims to enhance response rates in large B-cell lymphoma patients. The company is currently transitioning its manufact...

05:08pm, Tuesday, May 13, 2025
SilverBox Corp IV (NYSE: SBXD) – Quarterly Financial Overview SilverBox Corp IV is a blank check company that has yet to engage in any significant operations as of March 31, 2025. The company is primarily focusing on identifying potential merger or acquisition targets and has generated minimal re...

05:08pm, Tuesday, May 13, 2025
IRIDEX Corporation (NASDAQ: IRIX) has reported its Q1 results for the 2025 fiscal year, showcasing some fluctuations in financial performance. The company operates in the medical device sector, focusing specifically on ophthalmology. Positive Aspects: Total revenues: Increased by 1.1% from $11.7...

05:07pm, Tuesday, May 13, 2025
TWFG, Inc. (NASDAQ: TWFG) Financial Overview (Q1 2025) In the first quarter of 2025, TWFG, Inc. reported total revenues of $53.8 million, marking a significant 16.6% increase compared to $46.1 million in Q1 2024. Key revenue drivers included: Commission Income: Grew by 14.7% to $48.8 million, pr...

05:07pm, Tuesday, May 13, 2025
Carisma Therapeutics Inc. (NASDAQ: SESN) As of March 31, 2025, Carisma Therapeutics Inc. is currently in a critical phase of its operations, undergoing a significant transition as it seeks to explore strategic alternatives while having ceased development on its primary product candidates. Here ar...

05:07pm, Tuesday, May 13, 2025
BayFirst Financial Corp. (NASDAQ: BAFN) has recently released its quarterly financial report for the period ending March 31, 2025. Below is a summary of the key points from their income statement and current company operations, highlighting both positive and negative aspects. Positive Aspects: N...

05:06pm, Tuesday, May 13, 2025
Company Profile: Hudson Global, Inc. (NASDAQ: HSON) is a provider of Recruitment Process Outsourcing (RPO) services, tailored for new employment strategies globally. Recent Financial Performance: Revenue: $31.9 million in Q1 2025, a decrease of 6.0% from $33.9 million in Q1 2024. Operating Loss:...

05:06pm, Tuesday, May 13, 2025
Checkpoint Therapeutics, Inc. (OTCMKTS: CKPT) Checkpoint Therapeutics, a commercial-stage immunotherapy company focused on developing cancer treatments, has recently released its financial results for the quarter ended March 31, 2025. The company’s operations and financials are significant due to...

05:05pm, Tuesday, May 13, 2025
Genasys Inc. (NASDAQ: GNSS) Overview Genasys, Inc. is a global provider of Protective Communications solutions, focusing on real-time emergency communications through its Genasys Protect software platform and Long Range Acoustic Devices (LRAD). The company specializes in emergency warning and mas...

05:05pm, Tuesday, May 13, 2025
Vivani Medical, Inc. (NASDAQ: VANI) Vivani Medical is a clinical-stage biopharmaceutical company focused on developing innovative drug delivery systems. The company's main technology platform, NanoPortal™, aims to enable ultra-long-acting delivery of medications, particularly to improve adherence...

05:04pm, Tuesday, May 13, 2025
Company Overview: Tenon Medical, Inc. (NASDAQ: TNON) is a medical device company that focuses on developing minimally invasive surgical solutions. Their primary product, The Catamaran™ SI Joint Fusion System, is designed to treat sacroiliac joint disorders, which are often a cause of lower back p...

05:04pm, Tuesday, May 13, 2025
Elutia Inc. (NASDAQ: ELUT) recently released its quarterly report for the period ending March 31, 2025. Here's a brief overview of the company's performance along with notable items from its income statement. Key Points: Net Sales: Decreased by 9.9% to $6.03 million compared to $6.69 million in ...

05:04pm, Tuesday, May 13, 2025
Silexion Therapeutics Corp (NASDAQ: SLXN) is navigating the complexities of the biotechnology sector as it works on developing advanced treatments for pancreatic cancer. The latest quarterly report provides a detailed insight into its financial health and operational challenges. Key Highlights fr...